Brimotas T Eye Drop 5ml is a combination ophthalmic solution specifically formulated to manage elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Elevated IOP can damage the optic nerve, potentially leading to irreversible vision loss if left untreated.

This combination works by two complementary mechanisms: Brimonidine, an alpha-2 adrenergic agonist, reduces aqueous humor production and enhances uveoscleral outflow, while Timolol, a beta-blocker, decreases fluid production in the eye. The dual action ensures more effective IOP reduction compared to monotherapy.

Brimonidine and Timolol together provide rapid and sustained pressure control, making this solution ideal for patients who require enhanced IOP management. It is recommended as initial therapy in select cases or as adjunct therapy when other treatments do not achieve target pressure levels.